TCL Archive Bristol-Myers Squibb Co. has agreed to pay $450 million to settle class action suits from shareholders and separate civil claims by the Securities and Exchange Commission. The settlements stem from Bristol’s practice of building up wholesalers’ inventories and diverting operating income to enhance dividends. August 6, 2004
TCL Archive HHS Task Force Says NCI Drug Program Effective, Otters Suggestions; DeVita Responds March 26, 1982
TCL Archive Provenge Prolonged Prostate Cancer Survival By Seven Months, Study Finds September 26, 2003
